SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001140361-22-015567
Filing Date
2022-04-22
Accepted
2022-04-22 16:18:28
Documents
6
Period of Report
2022-06-02

Document Format Files

Seq Description Document Type Size
1 DEF14A ny20003930x1_def14a.htm DEF 14A 630912
2 logo_mirum.jpg GRAPHIC 16339
3 ny20003930x1-pc_1.jpg GRAPHIC 528514
4 ny20003930x1-pc_2.jpg GRAPHIC 456652
5 sig_christopherpeetzx2.jpg GRAPHIC 9723
6 sig_christopherpeetzx3.jpg GRAPHIC 10774
  Complete submission text file 0001140361-22-015567.txt   2038290
Mailing Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404
Business Address 950 TOWER LANE, SUITE 1050 FOSTER CITY CA 94404 650-667-4085
Mirum Pharmaceuticals, Inc. (Filer) CIK: 0001759425 (see all company filings)

IRS No.: 831281555 | State of Incorp.: DE | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-38981 | Film No.: 22845792
SIC: 2834 Pharmaceutical Preparations